About Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Princeton, United States. BMY has been publicly traded since 1972, giving it 54+ years of trading history.
Bristol-Myers Squibb Company (BMY) has been publicly traded since 1972, making it a 54-year-old public company. It operates in the Drug Manufacturers - General industry within the Healthcare sector. The company is headquartered in Princeton, United States and employs approximately 32,500 people. With a market capitalization of $120 billion, BMY is a large established company.
BMY trades on the US stock exchanges (NYSE/NASDAQ) and is classified as a large-cap-cap stock with a market capitalization of approximately $120 billion. The company employs approximately 32,500 people worldwide.
Key Statistics
- Current Price
- $59.29
- Market Cap
- $120.73B
- 52-Week High
- $62.89
- 52-Week Low
- $42.52
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
BMY Investment Performance
BMY has gained 11.2% year-to-date in 2026. Over the past 5 years, a $1,000 investment in BMY would have grown to $1,194, representing a 19.4% total return. Since its IPO in 1972, a $1,000 investment would now be worth $206,380.
$1,000 Invested in Bristol-Myers Squibb Company (BMY)
How much would $1,000 invested in BMY be worth today?
What would $1,000 invested in BMY 1 year ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2025 would be worth $1,033 as of May 2026, representing a +3.3% total return.
What would $1,000 invested in BMY 3 years ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2023 would be worth $1,022 as of May 2026, representing a +2.2% total return.
What would $1,000 invested in BMY 5 years ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2021 would be worth $1,194 as of May 2026, representing a +19.4% total return.
What would $1,000 invested in BMY 10 years ago be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) in 2016 would be worth $1,255 as of May 2026, representing a +25.5% total return.
What would $1,000 invested in BMY at IPO be worth today?
A $1,000 investment in Bristol-Myers Squibb Company (BMY) at IPO would be worth $206,380 as of May 2026, representing a +20538.0% total return.
Monthly Returns Heatmap
Over the past 53+ years (645 months), Bristol-Myers Squibb Company (BMY) has averaged a monthly return of +1.07% with a median return of +1.14%. The stock had 364 positive months (56%) and 276 negative months (43%). The best month in BMY's history was October 1974 with a +42.1% return, while the worst was April 2002 at -28.4%. Historically, October tends to be the strongest month (averaging +3.3%), and January the weakest (-0.5%).
BMY's longest winning streak was 10 consecutive months of gains, while its longest losing streak was 8 consecutive months of losses. The best full year was 1997 with a cumulative return of +61.5%, and the worst was 2002 at -63.8%.
Annual Returns
Over 54 years of trading history, Bristol-Myers Squibb Company (BMY) has delivered an average annual return of +12.83% with a median return of +11.51%. The compound annual growth rate (CAGR) is +10.15%. The stock posted gains in 41 years (76%) and losses in 13 years (24%).
BMY's best year was 1997 with a +77.07% gain, while the worst was 2002 at -52.40%. The longest streak of consecutive positive years was 18, and the longest losing streak was 2 years. BMY achieved double-digit gains (10%+) in 29 years. It suffered double-digit losses in 7 years.
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +11.21% | $53.31 | $59.28 |
| 2025 | +0.11% | $53.25 | $53.31 |
| 2024 | +15.81% | $45.98 | $53.25 |
| 2023 | -26.14% | $62.26 | $45.98 |
| 2022 | +18.98% | $52.33 | $62.26 |
| 2021 | +2.88% | $50.87 | $52.33 |
| 2020 | +0.41% | $50.66 | $50.87 |
| 2019 | +27.74% | $39.66 | $50.66 |
| 2018 | -12.90% | $45.53 | $39.66 |
| 2017 | +7.71% | $42.27 | $45.53 |
| 2016 | -13.49% | $48.86 | $42.27 |
| 2015 | +19.26% | $40.97 | $48.86 |
| 2014 | +14.18% | $35.88 | $40.97 |
| 2013 | +69.96% | $21.11 | $35.88 |
| 2012 | -3.81% | $21.95 | $21.11 |
| 2011 | +39.44% | $15.74 | $21.95 |
| 2010 | +8.73% | $14.48 | $15.74 |
| 2009 | +14.83% | $12.61 | $14.48 |
| 2008 | -6.03% | $13.42 | $12.61 |
| 2007 | +4.80% | $12.80 | $13.42 |
| 2006 | +19.90% | $10.68 | $12.80 |
| 2005 | -6.14% | $11.38 | $10.68 |
| 2004 | -7.24% | $12.26 | $11.38 |
| 2003 | +29.14% | $9.50 | $12.26 |
| 2002 | -52.40% | $19.95 | $9.50 |
| 2001 | -26.16% | $27.02 | $19.95 |
| 2000 | +17.10% | $23.08 | $27.02 |
| 1999 | -2.80% | $23.74 | $23.08 |
| 1998 | +42.95% | $16.61 | $23.74 |
| 1997 | +77.07% | $9.38 | $16.61 |
| 1996 | +32.16% | $7.10 | $9.38 |
| 1995 | +53.30% | $4.63 | $7.10 |
| 1994 | +6.11% | $4.36 | $4.63 |
| 1993 | -9.46% | $4.82 | $4.36 |
| 1992 | -21.18% | $6.11 | $4.82 |
| 1991 | +35.82% | $4.50 | $6.11 |
| 1990 | +24.08% | $3.63 | $4.50 |
| 1989 | +28.88% | $2.81 | $3.63 |
| 1988 | +14.40% | $2.46 | $2.81 |
| 1987 | +2.84% | $2.39 | $2.46 |
| 1986 | +27.54% | $1.88 | $2.39 |
| 1985 | +30.56% | $1.44 | $1.88 |
| 1984 | +28.17% | $1.12 | $1.44 |
| 1983 | +30.52% | $0.86 | $1.12 |
| 1982 | +31.20% | $0.65 | $0.86 |
| 1981 | +9.13% | $0.60 | $0.65 |
| 1980 | +40.53% | $0.43 | $0.60 |
| 1979 | +7.87% | $0.40 | $0.43 |
| 1978 | +10.25% | $0.36 | $0.40 |
| 1977 | +1.32% | $0.35 | $0.36 |
| 1976 | +2.09% | $0.35 | $0.35 |
| 1975 | +40.95% | $0.25 | $0.35 |
| 1974 | +11.81% | $0.22 | $0.25 |
| 1973 | -30.94% | $0.32 | $0.22 |
BMY Investment Analysis: Valuation, Risk & Dividends
Key factors to consider when evaluating Bristol-Myers Squibb Company as an investment
Valuation
BMY currently trades at a trailing P/E ratio of 17.1, which is considered moderate relative to the broader market. The forward P/E of 9.6 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 6.5. The price-to-sales ratio is 2.5.
Dividends
Bristol-Myers Squibb Company pays a dividend to shareholders with a current yield of 4.27%. This translates to $2.52 per share annually. The payout ratio of 72% indicates moderate dividend coverage.
Risk & Volatility
BMY has a beta of 0.27, indicating it is less volatile than the overall market. The stock's 52-week range is $42.52 to $62.89, and it currently trades near its 52-week high.
Analyst Ratings
Based on 25 analyst opinions, BMY has a consensus "hold" rating. The average price target of $62.36 suggests 5.6% upside from current levels.
Frequently Asked Questions: BMY
What sector is BMY in? ▼
BMY operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry. This sector includes pharmaceutical companies, biotechnology firms, medical device manufacturers, and healthcare providers.
How has BMY performed historically? ▼
Over 54 years of trading history, BMY has posted gains in 41 years (76% of the time). The best year was 1997 with a +77.1% return. Past performance does not guarantee future results.
How can I invest in BMY? ▼
You can invest in BMY through any brokerage account that offers access to US stock exchanges. Popular options include commission-free brokers like Fidelity, Charles Schwab, or Robinhood (US), or international brokers like Interactive Brokers. You can buy individual shares or invest through ETFs that hold BMY.
Does BMY pay dividends? ▼
Bristol-Myers Squibb Company pays a dividend to shareholders with a current yield of 4.27%. This translates to $2.52 per share annually. The payout ratio of 72% indicates moderate dividend coverage.
What does Bristol-Myers Squibb Company do? ▼
Bristol-Myers Squibb Company is a Drug Manufacturers - General company operating in the Healthcare sector. The company is headquartered in Princeton, United States.
What sector is BMY in? ▼
BMY operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.
When did BMY go public? ▼
Bristol-Myers Squibb Company went public in 1972, making it a 54-year-old public company as of 2026.
How much would $1,000 invested in BMY 5 years ago be worth today? ▼
A $1,000 investment in BMY five years ago would be worth approximately $1,194 today, representing a 19.4% return.
How much would $1,000 invested in BMY 10 years ago be worth today? ▼
A $1,000 investment in BMY ten years ago would be worth approximately $1,255 today, representing a 25.5% total return over the decade.
What is BMY's 3-year return? ▼
Over the past 3 years, BMY has returned 2.2%. A $1,000 investment would have grown to $1,022.
How much would $1,000 invested in BMY at IPO be worth today? ▼
If you invested $1,000 in BMY at its IPO in 1972, it would be worth approximately $206,380 today, a 20,538.0% return over 54 years.
Does BMY pay dividends? ▼
Yes, Bristol-Myers Squibb Company pays a dividend with a current yield of 4.27%, which is $2.52 per share annually.
What is BMY's market cap? ▼
Bristol-Myers Squibb Company has a market capitalization of $120 billion, classifying it as a large-cap company.
What is BMY's P/E ratio? ▼
BMY has a trailing P/E ratio of 17.1 and a forward P/E of 9.6, which measures how much investors are paying per dollar of earnings.
Is BMY a buy, hold, or sell? ▼
Based on 25 opinions, BMY has a consensus "hold" rating. The average price target is $62.36.
Last updated: 3/14/2026